可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Corti A,Gasparri A,Chen FX,et al.Characterisation of circulating chromogranin A in human cancer patients[J].Br J Cancer,1996,73(8):924-932.
[2]Curry WJ,Johnston CF,Hutton JC,et al.The tissue distribution of rat chromogranin A-derived peptides: evidence for differential tissue processing from sequence specific antisera[J].Histochemistry,1991,96(6):531-538.
[3]Ceconi C,Ferrari R,Bachetti T,et al.Chromogranin A in heart failure:a novel neurohumoral factor and a predictor formortality[J].Eur Heart J,2002,23(12):967-974.
[4]Omland T,Dickstein K,Syversen U.Association between p lasma chromogranin A concentration and long - term mortality after myocardial infarction[J].Am J Med,2003,114(1):25-30.
[5]Pieroni M,Corti A,Tota B,et al.Myocardial p roduction of chromogranin A in human heart: a new regulatory peptide of cardiac function[J].Eur Heart J,2007,28(9):1117-1127.
[6]Boriani G,Regoli F,Saporito D,et al.Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: time courses and prediction of response[J].Peptides,2006,27(7):1776-1786.
[7]Imbrogno S,Angelone T,Corti A,et al.Influence of vasostatins,the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action[J].Gen Comp Endocrinol,2004,139(1):20-28.
[8]Aardal S,Helle KB,Elsayed S,et al.Vasostatins,comprising the N-terminal domain of chromogranin-A,suppress tension in isolated human blood vessel segments[J]. J Neuroendocrinol,1993,5(4):405-412.
[9]Ratti S,Curnis F,Longhi R,et al.Structure-activity relationships of chromogranin A in cell adhesion. Identification of an adhesion site for fibroblasts and smooth muscle cells[J].J Biol Chem,2000,275(38):29257-29263.